EA200801854A1 - Новые композиции - Google Patents

Новые композиции

Info

Publication number
EA200801854A1
EA200801854A1 EA200801854A EA200801854A EA200801854A1 EA 200801854 A1 EA200801854 A1 EA 200801854A1 EA 200801854 A EA200801854 A EA 200801854A EA 200801854 A EA200801854 A EA 200801854A EA 200801854 A1 EA200801854 A1 EA 200801854A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compositions
new compositions
fpf
variability
uniformity
Prior art date
Application number
EA200801854A
Other languages
English (en)
Inventor
Джон Капекки
Джеймс Стифли
Тревор Рили
Original Assignee
Глаксо Груп Лимитед
3М Инновейтив Пропертиз Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38523271&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200801854(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Глаксо Груп Лимитед, 3М Инновейтив Пропертиз Компани filed Critical Глаксо Груп Лимитед
Publication of EA200801854A1 publication Critical patent/EA200801854A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/23—Solid substances, e.g. granules, powders, blocks, tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Abstract

Настоящее изобретение относится к новым фармацевтическим аэрозольным композициям, к способам их получения, к их применению в терапии, к дозирующим ингаляторам, содержащим указанные композиции, и к применению биосовместимых полимеров в уменьшении вариабельности однородности содержимого и/или в обеспечении улучшенной тонкодисперсной фракции (FPF) в указанных композициях.
EA200801854A 2006-03-22 2007-03-21 Новые композиции EA200801854A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78463406P 2006-03-22 2006-03-22
PCT/US2007/064462 WO2007109698A2 (en) 2006-03-22 2007-03-21 Novel formulations

Publications (1)

Publication Number Publication Date
EA200801854A1 true EA200801854A1 (ru) 2009-04-28

Family

ID=38523271

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200801854A EA200801854A1 (ru) 2006-03-22 2007-03-21 Новые композиции

Country Status (18)

Country Link
EP (1) EP2012797A2 (ru)
JP (1) JP2009530419A (ru)
KR (1) KR20080110854A (ru)
CN (1) CN101415428A (ru)
AR (1) AR060039A1 (ru)
AU (1) AU2007226899A1 (ru)
BR (1) BRPI0708798A2 (ru)
CA (1) CA2646236A1 (ru)
CR (1) CR10261A (ru)
EA (1) EA200801854A1 (ru)
IL (1) IL193723A0 (ru)
MA (1) MA30328B1 (ru)
MX (1) MX2008011967A (ru)
NO (1) NO20083760L (ru)
PE (1) PE20080124A1 (ru)
TW (1) TW200803870A (ru)
WO (1) WO2007109698A2 (ru)
ZA (1) ZA200807682B (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2400950B1 (en) 2009-02-26 2019-05-22 Glaxo Group Limited Pharmaceutical formulations comprising 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69413955T2 (de) * 1993-03-17 1999-04-01 Minnesota Mining & Mfg Aerosolzusammensetzung enthaltend einen aus ester-, amid- oder merkaptoester- derivat dispergiermittel
US6750210B2 (en) * 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
EP1305329B2 (en) * 2000-08-05 2015-03-18 Glaxo Group Limited 6.alpha.,9.alpha.-difluoro-17.alpha.-(2-furanylcarboxyl)oxy-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent

Also Published As

Publication number Publication date
CA2646236A1 (en) 2007-09-27
JP2009530419A (ja) 2009-08-27
AR060039A1 (es) 2008-05-21
MA30328B1 (fr) 2009-04-01
CN101415428A (zh) 2009-04-22
EP2012797A2 (en) 2009-01-14
CR10261A (es) 2008-11-26
MX2008011967A (es) 2009-01-14
KR20080110854A (ko) 2008-12-19
TW200803870A (en) 2008-01-16
AU2007226899A1 (en) 2007-09-27
PE20080124A1 (es) 2008-04-21
WO2007109698A2 (en) 2007-09-27
ZA200807682B (en) 2009-11-25
IL193723A0 (en) 2009-08-03
NO20083760L (no) 2008-12-17
WO2007109698A3 (en) 2008-12-18
BRPI0708798A2 (pt) 2011-06-14

Similar Documents

Publication Publication Date Title
EA200802012A1 (ru) Фармацевтические препараты в форме раствора для дозирующих ингаляторов под давлением
EA201491285A1 (ru) Улучшенные композиции и способы доставки омепразола и ацетилсалициловой кислоты
MX2010005631A (es) Nuevos compuestos de hidrocarburo ciclicos para el tratamiento de enfermedades.
MY168791A (en) Carbamate compounds and of making and using same
WO2012142511A3 (en) Orthomolecular compositions and their use in stabilizing the extracellular matrix
MX2007008379A (es) Metodos y composiciones para minimizar la acumulacion de insulina inhlable en los pulmones.
EA200800033A1 (ru) Композиция (варианты), способ ее получения, резервуар, содержащий указанную композицию, и способ лечения вирусных заболеваний с ее использованием
MX2019012657A (es) Inhibidores de tirosina cinasa de bruton.
WO2007149406A8 (en) Modified coagulation factor ix polypeptides and use thereof for treatment
EA201500432A1 (ru) Соединения боронатного эфира и его фармацевтические составы
BR112015009559A2 (pt) uso de composto antissenso na preparação de medicamento para tratamento de cãncer, composto antissenso e composição farmacêutica
LT2013015A (lt) Farmacinės kompozicijos
MX2009014235A (es) 4-bencilaminoquinolonas, composiciones farmaceuticas que las contiene y su uso.
ATE478658T1 (de) Zur verhinderung von missbrauch entworfene, feste arzneimittelform zur oralen verabreichung
BR112015018252A2 (pt) composição farmacêutica aquosa de dose fixa estável para administração nasal para um ser humano, composição de suspensão aquosa farmacêutica de dose fixa estável para administração nasal para um ser humano, suspensão estável adequada para administração nasal a um ser humano, método para tratar rinite em um ser humano necessitando do mesmo, uso da composição farmacêutica para administração nasal, método para liberar uma composição farmacêutica e kit
BR112014008609A2 (pt) composição farmacêutica, recipiente vedado, inalador de dosagem medida, método para o tratamento de um paciente que sofre ou provavelmente sofre de um distúrbio respiratório, e, método para fabricação de uma composição farmacêutica
UA104988C2 (ru) Производные пирониндола и способ их получения
EP2682101A3 (en) Inhalation Compositions Comprising Glucose Anhydrous
PH12014502662A1 (en) Novel dosage form and formulation of abediterol
SE0402345D0 (sv) A metered medication dose
CY1117596T1 (el) Φαρμακευτικeς συνθeσεις αερολyματος φορμοτερολης και διπροπιονικης βεκλομεθαζονης
EP2682100A3 (en) Inhalation Compositions Comprising Muscarinic Receptor Antagonist
MX2015009891A (es) Composiciones farmaceuticas que comprenden particulas cristalinas de multicomponentes adecuadas para usar en terapia de inhalacion.
EA200801854A1 (ru) Новые композиции
WO2006019894A3 (en) Nebulized pharmaceutical compositions for the treatment of bronchial disorders